Triapine
Triapine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
247 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Whooping cough | D014917 | EFO_0000650 | A37 | 2 | — | 2 | 1 | 5 | 10 |
| Pyelonephritis | D011704 | EFO_1001141 | N10-N16 | — | — | 6 | 1 | — | 7 |
| Pruritus | D011537 | — | L29 | — | — | 4 | 2 | 1 | 7 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | 3 | 1 | 1 | — | 6 |
| Diphtheria | D004165 | EFO_0005549 | A36 | 1 | — | 2 | 1 | — | 4 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | 1 | 1 | 2 | 4 |
| Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 2 | 2 | 4 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | — | — | 2 | — | 3 |
| Tetanus | D013742 | EFO_0005593 | A35 | 1 | — | 1 | 1 | — | 3 |
| Chronic pain | D059350 | — | — | — | — | — | 1 | 2 | 3 |
Show 13 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 17 | 12 | 1 | — | — | 23 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 9 | 6 | 1 | — | — | 14 |
| Neoplasms | D009369 | — | C80 | 10 | 4 | 2 | — | 1 | 14 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | 1 | — | 11 | 14 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 4 | 1 | — | — | 12 |
| Myeloid leukemia | D007951 | — | C92 | 7 | 6 | 1 | — | — | 11 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | 8 | 9 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 6 | 4 | 1 | — | — | 8 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | 7 | — | — | 7 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | — | — | 1 | — | 5 | 6 |
Show 43 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 10 | 6 | — | — | 1 | 13 |
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 7 | — | — | 2 | 11 |
| Lymphoma | D008223 | — | C85.9 | 6 | 3 | — | — | — | 7 |
| Lung neoplasms | D008175 | — | C34.90 | 3 | 5 | — | — | — | 6 |
| Recurrence | D012008 | — | — | 3 | 3 | — | — | — | 6 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 3 | — | — | — | 6 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 5 | 3 | — | — | — | 6 |
| Multiple myeloma | D009101 | — | C90.0 | 4 | 2 | — | — | — | 5 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 4 | 3 | — | — | — | 5 |
| Myeloid leukemia accelerated phase | D015465 | — | — | 2 | 3 | — | — | — | 4 |
Show 73 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hematologic neoplasms | D019337 | — | — | 5 | — | — | — | — | 5 |
| Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 3 | — | — | — | — | 3 |
| Preleukemia | D011289 | — | — | 3 | — | — | — | — | 3 |
| Syndrome | D013577 | — | — | 2 | — | — | — | 1 | 3 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | 1 | — | — | — | 2 | 3 |
| Periapical periodontitis | D010485 | EFO_1001391 | K04.5 | 1 | — | — | — | 2 | 3 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
| Residual neoplasm | D018365 | — | — | 2 | — | — | — | — | 2 |
| Gene rearrangement | D015321 | — | — | 1 | — | — | — | — | 1 |
| Trismus | D014313 | — | — | 1 | — | — | — | — | 1 |
Show 30 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 8 | 8 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 5 | 5 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 3 | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 3 | 3 |
| Healthy volunteers/patients | — | — | — | — | — | — | — | 3 | 3 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 3 | 3 |
| Radiculopathy | D011843 | — | M54.1 | — | — | — | — | 3 | 3 |
| Bursitis | D002062 | EFO_1000941 | M71.9 | — | — | — | — | 3 | 3 |
| Intervertebral disc degeneration | D055959 | — | — | — | — | — | — | 2 | 2 |
| Plantar fasciitis | D036981 | EFO_1001909 | M72.2 | — | — | — | — | 2 | 2 |
Show 111 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Triapine |
| INN | — |
| Description | 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, also called Triapine) is substance of interest for the treatment of cancer. It is a thiosemicarbazone derivative of 3-aminopyridine-2-carboxaldehyde. It presents an N-N-S array of donor sites that strongly bind iron, robbing iron-containing enzymes of their prosthetic group.
|
| Classification | Small molecule |
| Drug class | tricyclic compounds |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | NC(=S)N/N=C/c1ncccc1N |
Identifiers
| PDB | — |
| CAS-ID | 143621-35-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL231616 |
| ChEBI ID | — |
| PubChem CID | 9571836 |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use